{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:05:41Z","timestamp":1787987141798,"version":"build-2784847793"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,13]]},"DOI":"10.7759\/cureus.20380","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T11:09:49Z","timestamp":1639393789000},"source":"Crossref","is-referenced-by-count":4,"title":["A Case of Valproic-Acid Induced Hyperammonemic Encephalopathy"],"prefix":"10.7759","author":[{"given":"Kinza","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardhik","family":"Kummamuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Dasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoyaja","family":"Koritala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitesh K","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerti","family":"Deepika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-020-2343-x","article-title":"Valproate-induced hyperammonemic encephalopathy: a case report","volume":"14","author":"Shah S","year":"2020","unstructured":"Shah S, Wang R, Vieux U. Valproate-induced hyperammonemic encephalopathy: a case report. J Med Case Rep. 2020, 14:19. 10.1186\/s13256-020-2343-x","journal-title":"J Med Case Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2011.12.009","article-title":"Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management","volume":"34","author":"Chopra A","year":"2012","unstructured":"Chopra A, Kolla BP, Mansukhani MP, Netzel P, Frye MA. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management. Gen Hosp Psychiatry. 2012, 34:290-8. 10.1016\/j.genhosppsych.2011.12.009","journal-title":"Gen Hosp Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10100759","article-title":"Chronic valproic acid administration increases plasma, liver, and brain ammonia concentration and suppresses glutamine synthetase activity","volume":"10","author":"Badawy AA","year":"2020","unstructured":"Badawy AA, Elghaba R, Soliman M, Hussein AM, AlSadrah SA, Awadalla A, Abulseoud OA. Chronic valproic acid administration increases plasma, liver, and brain ammonia concentration and suppresses glutamine synthetase activity. Brain Sci. 2020, 10:759. 10.3390\/brainsci10100759","journal-title":"Brain Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10030187","article-title":"Valproic acid-induced hyperammonemic encephalopathy in a patient with bipolar disorder: a case report","volume":"10","author":"Wu MY","year":"2020","unstructured":"Wu MY, Chang FY, Ke JY, Chen CS, Lin PC, Wang TS. Valproic acid-induced hyperammonemic encephalopathy in a patient with bipolar disorder: a case report. Brain Sci. 2020, 10:187. 10.3390\/brainsci10030187","journal-title":"Brain Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/2193-1801-2-13","article-title":"Valproic acid-induced hyperammonemic encephalopathy - a potentially fatal adverse drug reaction","volume":"2","author":"Sousa C","year":"2013","unstructured":"Sousa C. Valproic acid-induced hyperammonemic encephalopathy - a potentially fatal adverse drug reaction. Springerplus. 2013, 2:13. 10.1186\/2193-1801-2-13","journal-title":"Springerplus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31817275b6","article-title":"A case of hyperammonemic encephalopathy after 11 years of valproate therapy","volume":"28","author":"Stewart JT","year":"2008","unstructured":"Stewart JT. A case of hyperammonemic encephalopathy after 11 years of valproate therapy. J Clin Psychopharmacol. 2008, 28:361-2. 10.1097\/JCP.0b013e31817275b6","journal-title":"J Clin Psychopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200501000-00012","article-title":"Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting","volume":"20","author":"Kimmel RJ","year":"2005","unstructured":"Kimmel RJ, Irwin SA, Meyer JM. Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting. Int Clin Psychopharmacol. 2005, 20:57-8. 10.1097\/00004850-200501000-00012","journal-title":"Int Clin Psychopharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2190\/XW8E-Q283-4429-QL71","article-title":"Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report","volume":"33","author":"Elgudin L","year":"2003","unstructured":"Elgudin L, Hall Y, Schubert D. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report. Int J Psychiatry Med. 2003, 33:91-6. 10.2190\/XW8E-Q283-4429-QL71","journal-title":"Int J Psychiatry Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s001340100937","article-title":"Simultaneous side effects of both clozapine and valproate","volume":"27","author":"Nicolai J","year":"2001","unstructured":"Nicolai J, Smith SJ, Keunen RW. Simultaneous side effects of both clozapine and valproate. Intensive Care Med. 2001, 27:943. 10.1007\/s001340100937","journal-title":"Intensive Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9114","article-title":"A case of valproate-induced hyperammonemic encephalopathy","volume":"12","author":"Zafar F","year":"2020","unstructured":"Zafar F, Billadeau BM, Ahmed AU. A case of valproate-induced hyperammonemic encephalopathy. Cureus. 2020, 12:e9114. 10.7759\/cureus.9114","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/8755122515605849","article-title":"Topiramate-related hyperammonemia","volume":"32","author":"Moore K","year":"2016","unstructured":"Moore K, Dixit D, Wagner M. Topiramate-related hyperammonemia. J Pharm Technol. 2016, 32:34-6. 10.1177\/8755122515605849","journal-title":"J Pharm Technol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2012.11.009","article-title":"Risperidone, a risk factor for valproate-induced encephalopathy?","volume":"35","author":"Rodrigues-Silva N","year":"2013","unstructured":"Rodrigues-Silva N, Ven\u00e2ncio \u00c2, Bou\u00e7a J. Risperidone, a risk factor for valproate-induced encephalopathy?. Gen Hosp Psychiatry. 2013, 35:452.e5-6. 10.1016\/j.genhosppsych.2012.11.009","journal-title":"Gen Hosp Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2019.05.005","article-title":"Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions","volume":"59","author":"Duman B","year":"2019","unstructured":"Duman B, Can KC, A\u011fta\u015f-Ertan E, et al.. Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions. Gen Hosp Psychiatry. 2019, 59:67-72. 10.1016\/j.genhosppsych.2019.05.005","journal-title":"Gen Hosp Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2018.03.073","article-title":"Valproic acid-induced hyperammonemia: Incidence, clinical significance, and treatment management","volume":"8","author":"Baddour E","year":"2018","unstructured":"Baddour E, Tewksbury A, Stauner N. Valproic acid-induced hyperammonemia: Incidence, clinical significance, and treatment management. Ment Health Clin. 2018, 8:73-7. 10.9740\/mhc.2018.03.073","journal-title":"Ment Health Clin"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/77716-a-case-of-valproic-acid-induced-hyperammonemic-encephalopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:54Z","timestamp":1707507234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/77716-a-case-of-valproic-acid-induced-hyperammonemic-encephalopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,13]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.20380","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,13]]}}}